ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 612,58
0,54%
Dow Jones
38 778,10
0,00%
DAX
18 091,90
0,10%
Brent Oil
83,88
-0,02%
Bitcoin
64 875,71
-2,42%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Miragen Therapeutics Inc (MGEN)

  7. Miragen Therapeutics Inc (MGEN) Actualités

MGEN

Miragen Therapeutics (MGEN)

Miragen Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:MGEN
DateHeureSourceTitreSymboleSociété
20/06/202323h23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MGENMiragen Therapeutics Inc
09/05/202322h11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MGENMiragen Therapeutics Inc
28/04/202314h29Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:MGENMiragen Therapeutics Inc
28/04/202314h27Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:MGENMiragen Therapeutics Inc
28/04/202314h25Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MGENMiragen Therapeutics Inc
10/03/202323h08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:MGENMiragen Therapeutics Inc
09/03/202313h25Edgar (US Regulatory)Annual Report (10-k)NASDAQ:MGENMiragen Therapeutics Inc
14/02/202322h55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MGENMiragen Therapeutics Inc
09/02/202318h02Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:MGENMiragen Therapeutics Inc
08/02/202300h46Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MGENMiragen Therapeutics Inc
08/02/202300h35Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:MGENMiragen Therapeutics Inc
14/11/202213h10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MGENMiragen Therapeutics Inc
19/08/202222h35Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MGENMiragen Therapeutics Inc
18/08/202222h42Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:MGENMiragen Therapeutics Inc
16/08/202212h07Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MGENMiragen Therapeutics Inc
04/02/202214h02Edgar (US Regulatory)Schedule 13gNASDAQ:MGENMiragen Therapeutics Inc
18/11/202112h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:MGENMiragen Therapeutics Inc
15/06/202123h31Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:MGENMiragen Therapeutics Inc
14/04/202122h17Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:MGENMiragen Therapeutics Inc
19/01/202113h00GlobeNewswire Inc.miRagen Therapeutics Announces Company Name Change to Viridian Therapeutics and New Executive Appointments, Including Expansi...NASDAQ:MGENMiragen Therapeutics Inc
05/01/202113h48Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:MGENMiragen Therapeutics Inc
15/12/202023h07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:MGENMiragen Therapeutics Inc
08/12/202022h12Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:MGENMiragen Therapeutics Inc
06/11/202022h24Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:MGENMiragen Therapeutics Inc
24/03/202020h28Edgar (US Regulatory)Unknown (sec Staff)NASDAQ:MGENMiragen Therapeutics Inc
31/10/201922h13Edgar (US Regulatory)Amended Small Company Offering and Sale of Securities Without Registration (d/a)NASDAQ:MGENMiragen Therapeutics Inc
15/08/201914h00GlobeNewswire Inc.miRagen Therapeutics to Present a Corporate Overview at the Robert W. Baird & Co. 2019 Global Healthcare ConferenceNASDAQ:MGENMiragen Therapeutics Inc
12/08/201914h00GlobeNewswire Inc.miRagen Therapeutics to Present a Corporate Overview at the 2019 Wedbush Healthcare ConferenceNASDAQ:MGENMiragen Therapeutics Inc
24/07/201914h00GlobeNewswire Inc.Miragen Therapeutics to Report Second Quarter 2019 Financial Results and Host a Conference Call on August 7thNASDAQ:MGENMiragen Therapeutics Inc
28/05/201922h30GlobeNewswire Inc.miRagen Therapeutics to Present a Corporate Overview at the Jefferies 2019 Global Healthcare ConferenceNASDAQ:MGENMiragen Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MGEN

Dernières Valeurs Consultées

NYSE
DIS
Walt Disney
EU
ORA
Orange
EU
VK
Vallourec
NYSE
MCD
McDonalds
EU
AI
Air Liquide
NYSE
NKE
Nike
EU
MC
Lvmh Moet Hennessy Louis...
NASDAQ
AMZN
Amazon.com
NASDAQ
MSFT
Microsoft
EU
SGO
Cie de SaintGobain
NASDAQ
GOOGL
Alphabet
EU
DG
Vinci
EU
HO
Thales
EU
LR
Legrand
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés